Riskpilot← Back to searchSign inGet full accessSkåde Lægehus I/S
I/SActiveCVR 25062671Stenvej 19, st. thGeneral medical practice activities · NACE 8621Est. 200011 employees
Revenue 2025
DKK 8,5M
+4% vs 2024
EBITDA margin
52.2%
-3% vs 2024
Equity ratio
73.8%
Financial strength
Net profit 2025
DKK 4,4M
-3% vs 2024
| Revenue | DKK 8,5M | +4% |
| EBITDA | DKK 4,4M | -3% |
| Net profit | DKK 4,4M | -3% |
| Total assets | DKK 1,8M | +6% |
| Equity | DKK 1,3M | +58% |
| Employees | 11 | — |
Legal name
Skåde Lægehus I/S
CVR number
25062671
Legal form
Interessentskab
NACE code
8621 · General medical practice activities
Founded
1. januar 2000
Share capital
—
Employees
11 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af interessenterne
Company purpose
Virksomhedens formål er at drive lægepraksis.
Address
Stenvej 19, st. th
Phone
+4586270011
Email
skaadelaegehus@dadlnet.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 6.679 | 6.989 | 7.393 | 8.203 | 8.503 |
| Staff expenses | -3.326 | -3.694 | -3.847 | -3.636 | -4.065 |
| EBITDA | 3.353 | 3.295 | 3.546 | 4.567 | 4.438 |
| Depreciation & amort. | -52 | -45 | -28 | -29 | -32 |
| EBIT | 3.301 | 3.250 | 3.518 | 4.538 | 4.406 |
| Net financials | -6 | -6 | -3 | 3 | 0 |
| Profit before tax | 3.295 | 3.244 | 3.515 | 4.540 | 4.406 |
| Tax | -0 | -0 | -0 | -0 | -0 |
| Net profit | 3.295 | 3.244 | 3.515 | 4.540 | 4.406 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1.532 | 1.339 | 1.323 | 1.720 | 1.821 |
| Equity | 643 | 773 | 658 | 852 | 1.344 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 889 | 566 | 665 | 868 | 478 |
| Total debt | 889 | 566 | 665 | 868 | 478 |
EBITDA margin
52.2%
This company
15.8%
Market median
+230% vs market
20212025
Equity ratio
73.8%
This company
38.2%
Market median
+93% vs market
20212025
Return on equity
327.9%
This company
18.4%
Market median
+1682% vs market
20212025
Net profit margin
51.8%
This company
8.1%
Market median
+540% vs market
20212025
Asset turnover
4.67×
This company
1.12×
Market median
+317% vs market
20212025
Debt / equity
0.36×
This company
0.62×
Market median
+42% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
JM Management | Management | 2016 |
AK Management | Management | 2019 |
MA Management | Management | 2017 |
| Former (2) | ||
SS Stakeholder | Stakeholder | 2000 – 2016 |
LB Stakeholder | Stakeholder | 2000 – 2016 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Skåde Lægehus I/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sven Sigurd Wemmelund | Stakeholder | 0 companies |
| Jacob Mühlbach Breining | Management | 0 companies |
| Anne Kathrine Erdmann Andersen | Management | 0 companies |
| Lisbeth Borup Wemmelund | Stakeholder | 0 companies |
| Marie Aaen | Management | 0 companies |